NOVEL NMR STUDIES OF HEME PROTEINS INVOLVED IN ANEMIA
NOVEL NMR STUDIES OF HEME PROTEINS INVOLVED IN ANEMIA
批准号:
2145738
负责人:
RONALD D GUILES
金额:
$7.35万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-06-01 至 1998-05-31
关键词:
autooxidation chemical models cytochrome b drug design /synthesis /production electrochemistry electron transport hemolytic anemia intermolecular interaction methemoglobin myoglobin nuclear magnetic resonance spectroscopy pathologic process protein structure function site directed mutagenesis thermodynamics
中文摘要
几类贫血性疾病,包括一些相对
常见的严重溶血性疾病是由于
使高铁血红蛋白在红细胞中的含量过高。 这些
病理状况是两种不平衡的结果,
竞争过程,血红蛋白自氧化的内源性速率
并被细胞色素b5再还原。 这一建议是针对
获得与这些病理学直接相关的基本化学知识
通过使用发散切削刃的聚焦阵列,
顺磁共振新多维异谱NMR
血红素蛋白质,涉及高产率表达的重组方法
系统和新型电化学方法。 小说的异质性
多维核磁共振方法的建议是唯一适合的研究
血红素蛋白质,更重要的是血红素蛋白质的研究
配合物 这些方法最近已被应用于研究
细胞色素b5 -细胞色素c复合物,一个重要的模型,
生物电子转移 我们的目的是扩大这些研究,
细胞色素b5 -肌红蛋白复合物作为模型的研究,
生理学相关的细胞色素b5的溶液结构
血红蛋白复合物 虽然组成蛋白质的结构
(细胞色素b5、血红蛋白和肌红蛋白)是已知的,
复合物抵抗晶体学表征。 现代核磁共振
方法和新的扩展,这些方法提出了这里提供
独特的能力,获得对这些方向的约束,
在生理相关条件下,复合物和溶液中的蛋白质
条件 我们还计划研究血红素蛋白质
控制中点潜力和重组能量。 这些研究
将使更多的定量解释的机制,
加速自氧化或改变自然界中再还原的速率
血红蛋白的突变体 中点电位的初步测量
细胞色素b5的合成已使用薄层细胞制成。 小说
采用表面改性电极的电化学方法应
能够直接测量组分的电子转移速率,
从而可以更深入地了解影响重组因素
能量和电子之间的组件转移率
生理复合体 最后,一个长期目标与
上述具体建议涉及定点药物设计
旨在减轻贫血的影响。 一旦我们获得足够的
关于控制中点电位的蛋白质因子的信息,
自动氧化和再还原的速率,我们希望设计新的
可以稳定突变的血红蛋白或改变血红蛋白的
细胞色素b5的中点电位,以促进
高铁血红蛋白
英文摘要
Several classes of anemic disorders including a number of relatively
common, serious hemolytic conditions are the result of the accumulation
of methemoglobin to anomalously high levels in red blood cells. These
pathological conditions are the result of an imbalance between two
competing processes, the endogenous rate of autoxidation of hemoglobin
and its re-reduction by cytochrome b5. This proposal is directed at
obtaining basic chemical knowledge directly related to these pathological
conditions through the use of a focused array of divergent cutting edge
technologies; novel multidimensional heteronuclear NMR of paramagnetic
heme-proteins, recombinant methods involving high yield expression
systems and novel electrochemical methods. The novel heteronuclear
multidimensional NMR methods proposed are uniquely suited to the study of
heme-proteins and more importantly to the study of heme-protein
complexes. These methods have recently been applied to the study of the
cytochrome b5 - cytochrome c complex, an important model for long-range
biological electron transfer. It is our intent to extend these studies
to the study of the cytochrome b5 - myoglobin complex as a model for the
solution structure of the physiologically relevant cytochrome b5 -
hemoglobin complex. Although the structures of the component proteins
(cytochrome b5, hemoglobin and myoglobin) are known, the structure of the
complex has resisted crystallographic characterization. Modern NMR
methods and novel extensions of those methods proposed here offer the
unique capability of obtaining constraints on the orientation of these
proteins in complex and in solution under physiologically relevant
conditions. We also plan to study the mechanism by which heme-proteins
control midpoint potential and reorganizational energies. These studies
will then enable more quantitative interpretation of the mechanism of
accelerated autoxidation or altered rates of re-reduction in natural
mutants of hemoglobin. Preliminary measurements of midpoint potentials
of cytochrome b5 have been made using thin layer cells. Novel
electrochemical methods employing surface modified electrodes should
enable direct measurement of electron transfer rates of components and
hence allow greater insights into factors effecting reorganizational
energy and rates of electron transfer between components of the
physiological complex. Finally, a long-range goal coupled to the
specific proposals described above, involves site directed drug design
directed at alleviating the anemic effects. Once we have obtained enough
information regarding protein factors which control midpoint potential,
rates of autoxidation, and re-reduction we hope to design novel
pharmaceutical agents which can stabilize mutant hemoglobins or alter the
midpoint potential of cytochrome b5 to facilitate re-reduction of
methemoglobin.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NOVEL NMR STUDIES OF HEME PROTEINS INVOLVED IN ANEMIA
-
批准号:6309127
-
项目类别:
-
资助金额:$0.75万
-
财政年份:2000
-
负责人:RONALD D GUILES
-
依托单位:
NMR STUDIES OF ISOTOPICALLY ENRICHED HUMAN INTERLEUKIN 5
-
批准号:6309128
-
项目类别:
-
资助金额:$0.75万
-
财政年份:2000
-
负责人:RONALD D GUILES
-
依托单位:
NOVEL NMR STUDIES OF HEME PROTEINS INVOLVED IN ANEMIA
-
批准号:6298124
-
项目类别:
-
资助金额:$0.75万
-
财政年份:1999
-
负责人:RONALD D GUILES
-
依托单位:
NMR STUDIES OF ISOTOPICALLY ENRICHED HUMAN INTERLEUKIN 5
-
批准号:6298125
-
项目类别:
-
资助金额:$0.75万
-
财政年份:1999
-
负责人:RONALD D GUILES
-
依托单位:
NOVEL NMR STUDIES OF HEME PROTEINS INVOLVED IN ANEMIA
-
批准号:6281563
-
项目类别:
-
资助金额:$0.15万
-
财政年份:1998
-
负责人:RONALD D GUILES
-
依托单位:
NMR STUDIES OF ISOTOPICALLY ENRICHED HUMAN INTERLEUKIN 5
-
批准号:6281564
-
项目类别:
-
资助金额:$0.79万
-
财政年份:1998
-
负责人:RONALD D GUILES
-
依托单位:
NMR STUDIES OF ISOTOPICALLY ENRICHED HUMAN INTERLEUKIN 5
-
批准号:6252078
-
项目类别:
-
资助金额:$0.52万
-
财政年份:1997
-
负责人:RONALD D GUILES
-
依托单位:
TRAINING IN USE OF DMX ELECTRONICS
-
批准号:6252079
-
项目类别:
-
资助金额:$0.52万
-
财政年份:1997
-
负责人:RONALD D GUILES
-
依托单位:
NOVEL NMR STUDIES OF HEME PROTEINS INVOLVED IN ANEMIA
-
批准号:2145739
-
项目类别:
-
资助金额:$7.77万
-
财政年份:1993
-
负责人:RONALD D GUILES
-
依托单位:
NOVEL NMR STUDIES OF HEME PROTEINS INVOLVED IN ANEMIA
-
批准号:3464886
-
项目类别:
-
资助金额:$10.61万
-
财政年份:1993
-
负责人:RONALD D GUILES
-
依托单位:
NOVEL NMR STUDIES OF HEME PROTEINS INVOLVED IN ANEMIA
-
批准号:2145737
-
项目类别:
-
资助金额:$13.64万
-
财政年份:1993
-
负责人:RONALD D GUILES
-
依托单位:
NOVEL NMR STUDIES OF HEME PROTEINS INVOLVED IN ANEMIA
-
批准号:2430208
-
项目类别:
-
资助金额:$8.22万
-
财政年份:1993
-
负责人:RONALD D GUILES
-
依托单位:
海外基金